Menlo Park, California
United States
30
2025-09-11
19
2022-12-27
These are the the leading inventors for applications assigned to Chimera Bioengineering, Inc.:
Chimera Bioengineering, Inc. based in Menlo Park, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Compositions and Methods for Activating Natural Killer Cells
#2 | 2024-12-26IL-18 Variants and Uses Thereof
#3 | 2023-01-26Mercury Controlled Gene Expression
#4 | 2022-10-13Gold Optimized CAR Natural Killer cells
#5 | 2022-06-30 ✅ Patent 11,535,853 granted on 2022-12-27Gold optimized CAR T-cells
#6 | 2022-06-16 ✅ Patent 11,572,566 granted on 2023-02-07Gold optimized CAR t-cells
#7 | 2021-12-23 ✅ Patent 11,311,577 granted on 2022-04-26Coordinating gene expression using RNA destabilizing elements
#8 | 2021-11-04 ✅ Patent 11,718,929 granted on 2023-08-08Methods for making novel antigen binding domains
#9 | 2021-10-28Ligand Matched Transcription Control, Control Devices, and Solute Carriers
#10 | 2021-09-23Gold Optimized CAR T-cells
#11 | 2021-09-23Coordinating Gene Expression Using RNA Destabilizing Elements
#12 | 2021-02-18Combination Therapy with Gold Controlled Transgenes
#13 | 2020-12-10Gold Optimized CAR T-cells
#14 | 2020-11-12 ✅ Patent 10,858,660 granted on 2020-12-08Gold optimized CAR T-cells
#15 | 2020-11-12Gold Optimized CAR T-cells
#16 | 2020-04-30 ✅ Patent 10,669,549 granted on 2020-06-02Gold optimized CAR T-cells
#17 | 2020-01-30 ✅ Patent 11,459,572 granted on 2022-10-04Gold optimized CAR T-cells
#18 | 2019-12-05 ✅ Patent 10,675,305 granted on 2020-06-09Coordinating gene expression using RNA destabilizing elements
#19 | 2019-11-21 ✅ Patent 10,688,132 granted on 2020-06-23Coordinating gene expression using RNA destabilizing elements
#20 | 2019-10-10 ✅ Patent 10,472,637 granted on 2019-11-12Gold optimized CAR T-cells
#21 | 2019-08-15 ✅ Patent 11,110,125 granted on 2021-09-07Coordinating gene expression using RNA destabilizing elements
#22 | 2019-06-13 ✅ Patent 11,085,917 granted on 2021-08-10Methods for making novel antigen binding domains
#23 | 2019-01-24 ✅ Patent 10,323,249 granted on 2019-06-18Gold optimized CAR T-cells
#24 | 2018-05-24 ✅ Patent 11,530,272 granted on 2022-12-20Smart car devices, DE car polypeptides, side CARs and uses thereof
#25 | 2018-05-10Ligand Matched Transcription Control, Control Devices, and Solute Carriers
#26 | 2018-03-01 ✅ Patent 10,323,248 granted on 2019-06-18Gold optimized CAR T-cells
#27 | 2018-02-01 ✅ Patent 10,508,152 granted on 2019-12-17Smart CAR devices, DE CAR polypeptides, side CARs and uses thereof
#28 | 2017-11-23 ✅ Patent 10,222,369 granted on 2019-03-05Methods for making novel antigen binding domains
#29 | 2017-06-08 ✅ Patent 11,052,111 granted on 2021-07-06Smart CAR devices and DE CAR polypeptides for treating disease and methods for enhancing immune responses
#30 | 2016-09-22 ✅ Patent 9,777,064 granted on 2017-10-03Smart CAR devices, DE CAR polypeptides, side CARs and uses thereof
Also check out Chimera Bioengineering, Inc.'s (Menlo Park, United States) applicant profile with 20 patent applications submitted.
113341 ⎘